Clinical Trials | June 18, 2026
Suven reports positive Phase 2b results for Ropanicant in major depressive disorder
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance
The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months
Developed by the Sudha Gopalakrishnan Brain Centre, the publicly accessible ANCHOR atlas maps over 200 brainstem structures at cellular resolution, offering new possibilities for neuroscience research and clinical applications
The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
The results come from post-hoc analyses of more than 1,500 women enrolled in the Phase 3 ATTAIN-1 and ATTAIN-2 trials, presented at the American Diabetes Association’s 86th Scientific Sessions
The session created a platform for meaningful discussions on the challenges of the disease and the importance of timely intervention
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Fertility platform launches flagship clinic with advanced IVF tech
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
